Launxp Biomedical Co (ROCO:6876) ROE % Adjusted to Book Value: -9.49% (As of Dec. 2025)


ROCO:6876 Launxp Biomedical Co Ltd ROCO:6876
11 GF Score
Price NT$15.80
! 4 Warning Signs
View Full Analysis

What is Launxp Biomedical Co ROE % Adjusted to Book Value?

Launxp Biomedical Co ROCO:6876 -3.07% 11 ROE % Adjusted to Book Value is -9.49% as of Dec. 2025. GuruFocus rates ROCO:6876 with a GF Score™ of 11/100. The stock has 4 warning signs investors should review.

Launxp Biomedical Co's ROE % for the quarter that ended in Dec. 2025 was -42.21%. Launxp Biomedical Co's PB Ratio for the quarter that ended in Dec. 2025 was 4.45. Launxp Biomedical Co's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 was -9.49%.

Launxp Biomedical Co ROE % Adjusted to Book Value Related Terms

Launxp Biomedical Co ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Launxp Biomedical Co's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Launxp Biomedical Co ROE % Adjusted to Book Value Chart

Launxp Biomedical Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE % Adjusted to Book Value
Get a 7-Day Free Trial 0.00 0.00 0.00 -8.95 -13.71

Launxp Biomedical Co Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 -8.13 -11.00 -18.73 -9.49

ROCO:6876 vs VRTX, REGN, ALNY: ROE % Adjusted to Book Value Comparison

For the Biotechnology subindustry, Launxp Biomedical Co's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Launxp Biomedical Co ROE % Adjusted to Book Value vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Launxp Biomedical Co's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Launxp Biomedical Co's ROE % Adjusted to Book Value falls into.


ROCO:6876
11GF Score
Launxp Biomedical Co Ltd ROCO:6876
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Launxp Biomedical Co ROE % Adjusted to Book Value Calculation

Launxp Biomedical Co's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-61.03% / 4.45
=-13.71%

Launxp Biomedical Co's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-42.21% / 4.45
=-9.49%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of -9.49% mean?
Launxp Biomedical Co (ROCO:6876) has a ROE % Adjusted to Book Value of -9.49% as of Dec. 2025. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Launxp Biomedical Co and its competitors.
Is Launxp Biomedical Co's ROE % Adjusted to Book Value too high?
Launxp Biomedical Co's current ROE % Adjusted to Book Value is -9.49%. Overall, Launxp Biomedical Co has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Launxp Biomedical Co's ROE % Adjusted to Book Value compare to VRTX and REGN?
Launxp Biomedical Co's ROE % Adjusted to Book Value of -9.49% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Biotechnology company?
A good ROE % Adjusted to Book Value depends on the Biotechnology industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Launxp Biomedical Co and its competitors. Launxp Biomedical Co's current ROE % Adjusted to Book Value is -9.49%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Launxp Biomedical Co stock overvalued right now?
Launxp Biomedical Co (ROCO:6876) has a current ROE % Adjusted to Book Value of -9.49%. The current ROE % Adjusted to Book Value is -9.49%. Launxp Biomedical Co's overall GF Score™ is 11/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Launxp Biomedical Co (ROCO:6876), the current ROE % Adjusted to Book Value is -9.49% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Launxp Biomedical Co Business Description

Address 10F, No. 51, Section 2, Gongyi Road, Nantun District, Taichung, TWN, 408
Launxp Biomedical Co Ltd is a company that researches, designs and develops Cancer drug rapid screening platform and Early development evaluation and technology licensing of generic drugs for cancer treatment. The company mainly focuses on the screening of development drugs, formulation of development strategies, project management, planning and execution of regulations and clinical trials, etc.
11GF Score

Get the complete analysis for ROCO:6876

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$15.80
Price